Sidley Austin LLP

Sidley Austin LLP advises biotech, biopharma, medical devices, and healthcare companies across the product lifecycle, with remarkable strength in regulatory and transactional matters. Its regulatory practice ensures client compliance across the marketing authorization, manufacturing, supply chain, distribution, and market access phases. On the transactional side, it handles high-value M&A and IPOs, as well as licensing agreements. The practice is led by San Francisco-based Sharon Flanagan, vastly experienced in corporate and capital markets transactions and governance matters. Washington DC’s Torrey Cope is another key member in the practice, specializing in FDA regulatory issues. Transactional lawyer Jon Olsen joined the San Diego team from Goodwin.